Filter
438
Text search:
drug
stability
testing
Featured
Recommendations
37
New Publications
109
Language
Document type
No document type
268
Guidelines
63
Studies & Reports
56
Manuals
27
Strategic & Response Plan
13
Situation Updates
4
Training Material
3
Fact sheets
3
Infographics
1
Countries / Regions
India
21
Uganda
14
Kenya
14
Liberia
13
South Africa
12
Global
11
Nigeria
10
Zambia
10
Tanzania
10
Ethiopia
9
Sierra Leone
8
Malawi
8
Western and Central Europe
8
Rwanda
7
Zimbabwe
6
Bangladesh
6
Namibia
6
Asia
6
Ghana
5
Cambodia
5
Ukraine
5
Nepal
4
Botswana
4
Eastern Europe
4
South Sudan
3
Mozambique
3
Middle East and North Africa
3
Guinea
2
Senegal
2
Congo, Democratic Republic of
2
USA
2
Lesotho
2
West and Central Africa
2
South–East Asia Region
2
Latin America and the Carribbean
2
Eastern Europe and Central Asia
2
Russia
2
Burkina Faso
1
Philippines
1
Iraq
1
Syria
1
China
1
Indonesia
1
Malaysia
1
Sudan
1
Colombia
1
Myanmar / Burma
1
Yemen
1
East and Southern Africa
1
Western Pacific Region
1
Africa
1
Albania
1
Moldova
1
Australia
1
Vietnam
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
175
Clinical Guidelines
41
Pharmacy & Technologies
19
Public Health
13
Key Resources
13
Women & Child Health
12
Capacity Building
8
Toolboxes
HIV
55
Mental Health
34
TB
32
Pharmacy
27
COVID-19
23
NTDs
15
Malaria
15
AMR
14
Ebola & Marburg
10
Rapid Response
9
Caregiver
6
Health Financing Toolbox
5
Conflict
4
Planetary Health
4
NCDs
4
2.0 Rapid Response
4
Natural Hazards
3
Global Health Education
3
Refugee
2
Specific Hazards
2
Disability
1
Zika
1
Social Ethics
1
World Drug Report 2018
-4-
International Journal of Drug Policy 24 (2013) e91-98
28 January 2021. The purpose of this document is to provide interim guidance on laboratory biosafety related to the testing of clinical specimens of patients.
After completing this activity, pharmacists should be able to:
1. List populations for which the compounding of an oral liquid may be necessary
2. Outline necessary considerations that should be made by the pharmacist to ensure product stability
...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the dru
...
Am. J. Trop. Med. Hyg., 106 (Suppl 5), 2022, pp. 56–60. Lymphatic filariasis (LF) is a parasitic disease that is a major cause of chronic disability in the developing world. According to the 2021–2030 road map for neglected tropical diseases (NTDs) published by the World Health Organization (WHO
...
Antimicrobial Resistance Surveillance and Research Network | This document contains detail procedures on sample collection, transport, isolation, identification of fungi for the diagnosis of invasive fungal infections and antifungal susceptibility testing
...
The mandate of the National Tuberculosis Control Programme is to provide leadership and stewardship to accelerate intense and coordinated efforts to reduce the adult TB burden of 290 per 100,000 population recently established in the 2013 National TB Prevalence Survey. Other key challenges are low T
...
The aim of the meeting was to broaden the network’s initiatives. Preliminary work involved integrating laboratory testing for skin NTDs other than Buruli ulcer, such as cutaneous leishmaniasis, mycetoma, leprosy and yaws, while extending the netwo
...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spr
...
ECDC Technical Report
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 i ...
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 i ...
Nat Commun 9, 5370 (2018). https://doi.org/10.1038/s41467-018-07804-8. Mycobacterium ulcerans is the causative agent of Buruli ulcer, a neglected tropical skin disease that is most commonly found in children from West and Central Africa. Despite the severity of the infection, therapeutic options are
...
Drugs and medical supplies are dispensed at the cutting edge level of the interface between the public health system and the people. Availability or lack of it brings either credit or discredit to the public health system. The primary reason for holding stocks of medicines and medical supplies in a
...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a
...
The 2022 report reviews the global malaria diagnostics market and technological landscape to support Unitaid’s 2023–2027 strategy for quality malaria case management. The report highlights the stalled progress of malaria control efforts, the gaps in access to diagnostics and the public health im
...
This document provides technical guidance for manufacturers seeking World Health Organization (WHO) prequalification of in vitro diagnostic devices (IVDs) for malaria, with a focus on rapid diagnostic tests (RDTs) for symptomatic patients. It summarises the minimum performance requirements, includin
...
This document provides technical guidance for manufacturers seeking World Health Organization (WHO) prequalification of in vitro diagnostic devices (IVDs) for malaria, with a focus on rapid diagnostic tests (RDTs) for symptomatic patients. It summarises the minimum performance requirements, includin
...
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good manufacturing practices (GMP) is one of the most important tools for this measure.
Rappart sur les populations clés.
